ArticleTransboundary and emerging diseases2023
International Importation Risk Estimation of SARS-CoV-2 Omicron Variant with Incomplete Mobility Data.
Article in Transboundary and emerging diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A novel Omicron subvariant named BQ.1 emerged in Nigeria in July 2022 and has since become a dominant strain, causing a significant number of repeated infections even in countries with high-vaccination rates. Due to the high flow of people between Western Africa and other non-African countries, there is a high risk of Omicron BQ.1 being introduced to other countries from Western Africa. In this context, we developed a model based on deep neural networks to estimate the probability that the Omicron BQ.1 introduced to other countries from Western Africa based on the incomplete population mobility data from Western Africa to other non-African countries. Our study found that the highest risk was in France and Spain during the study period, while the importation risk of other 13 non-African countries including Canada and the United States is also high. Our approach sheds light on how deep learning techniques can assist in the development of public health policies, and it has the potential to be extended to other types of viruses.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.